Relmada Therapeutics, Inc.

News

Latest Press Releases, Articles & Media Resources

Press Releases

January 10, 2020
Relmada Therapeutics Strengthens Financial Operations with Addition of Maged Shenouda as Chief Financial Officer

NEW YORK, Jan. 10, 2020 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Maged Shenouda has been appointed the Company's new Chief Financial Officer (CFO).  Mr. Shenouda, who has nearly 30 years of biotechnology and equity research experience, has also… Read More »

More Press Releases